Literature DB >> 22925811

Susceptibility to chronic hepatitis C virus infection is influenced by sequence differences in immunodominant CD8+ T cell epitopes.

Susanne Ziegler1, Marianne Ruhl, Hannelore Tenckhoff, Manfred Wiese, Falko M Heinemann, Peter A Horn, Ulrich Spengler, Christoph Neumann-Haefelin, Jacob Nattermann, Jörg Timm.   

Abstract

BACKGROUND & AIMS: The antiviral immune response against HCV by CD8+ T cells plays a central role in viral containment. In a large HCV genotype 1b outbreak in Ireland, HLA-B(∗)08 was identified as a risk allele for chronic infection and HLA-A(∗)03 and HLA-B(∗)27 were associated with higher clearance rates. Here we took advantage of a similar large common source HCV genotype 1b outbreak (East-German cohort) to determine the role of HLA class I alleles and the sequence of the infection source, in immunodominant CD8+ T cell epitopes for disease outcome.
METHODS: HLA-type and IL28B genotype were determined in 216 patients with chronic and 95 with spontaneously resolved HCV infection. The viral sequence in immunodominant epitopes was determined in the infection source and in patients with chronic infection.
RESULTS: In contrast to the Irish cohort, HLA-B(∗)08, HLA-A(∗)03 and HLA-B(∗)27 were neutral for disease outcome even when the cohort was stratified for the IL28B genotype. Sequence analysis of the immunodominant epitopes revealed that pre-existing substitutions in the infection source of both cohorts influenced the impact of the corresponding HLA-allele. The immunodominant epitopes presented by the "protective" alleles HLA-A(∗)03 and -B(∗)27 in the Irish cohort contained substitutions in the source virus of the East-German outbreak. Importantly, the pre-existing substitutions altered subsequent selection pressure and viral evolution in the East-German cohort.
CONCLUSIONS: This study highlights that subtle sequence differences in the infection source may have profound effects on the ability to clear HCV infection in the presence of particular HLA class I alleles.
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22925811     DOI: 10.1016/j.jhep.2012.08.016

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  8 in total

1.  Impact of sequence variation in a dominant HLA-A*02-restricted epitope in hepatitis C virus on priming and cross-reactivity of CD8+ T cells.

Authors:  Susanne Ziegler; Kathrin Skibbe; Andreas Walker; Xiaoyu Ke; Falko M Heinemann; Andreas Heinold; Juk Yee Mok; Wim J E van Esch; Dongliang Yang; Matthias Wölfl; Jörg Timm
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

Review 2.  Mutational escape of CD8+ T cell epitopes: implications for prevention and therapy of persistent hepatitis virus infections.

Authors:  Joerg Timm; Christopher M Walker
Journal:  Med Microbiol Immunol       Date:  2014-12-24       Impact factor: 3.402

Review 3.  Hepatitis C virus adaptation to T-cell immune pressure.

Authors:  A Plauzolles; M Lucas; S Gaudieri
Journal:  ScientificWorldJournal       Date:  2013-03-11

4.  Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.

Authors:  Karen Fitzmaurice; Jacob Hurst; Megan Dring; Andri Rauch; Paul J McLaren; Huldrych F Günthard; Clair Gardiner; Paul Klenerman
Journal:  Gut       Date:  2014-07-04       Impact factor: 23.059

5.  The interaction of genetic determinants in the outcome of HCV infection: evidence for discrete immunological pathways.

Authors:  T J Hydes; B Moesker; J A Traherne; S Ashraf; G J Alexander; B D Dimitrov; C H Woelk; J Trowsdale; S I Khakoo
Journal:  Tissue Antigens       Date:  2015-10

Review 6.  HCV-Specific T Cell Responses During and After Chronic HCV Infection.

Authors:  Hendrik Luxenburger; Christoph Neumann-Haefelin; Robert Thimme; Tobias Boettler
Journal:  Viruses       Date:  2018-11-17       Impact factor: 5.048

Review 7.  Adaptive Immune Response against Hepatitis C Virus.

Authors:  Janine Kemming; Robert Thimme; Christoph Neumann-Haefelin
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

Review 8.  Uncovering Resistance to Hepatitis C Virus Infection: Scientific Contributions and Unanswered Questions in the Irish Anti-D Cohort.

Authors:  Jamie A Sugrue; Cliona O'Farrelly
Journal:  Pathogens       Date:  2022-02-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.